A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/535 (2006.01) A61K 31/40 (2006.01) A61K 31/4035 (2006.01) A61K 31/404 (2006.01) A61K 31/435 (2006.01) A61K 31/438 (2006.01) A61K 31/445 (2006.01) A61K 31/451 (2006.01) A61K 31/4545 (2006.01) A61K 31/47 (2006.01) A61K 31/4709 (2006.01) A61K 31/675 (2006.01)
Patent
CA 2287487
The present invention provides the use of an NK-1 receptor antagonist, optionally with an anorectic agent, for the manufacture of a medicament for the treatment or prevention of eating disorders, methods of treatment using the NK-1 receptor antagonist and pharmaceutical compositions and products containing it.
La présente invention porte sur l'utilisation d'un antagoniste du récepteur de NK-1, éventuellement avec un agent anorexique, en vue de fabriquer un médicament destiné à être utilisé dans le traitement ou la prévention des troubles alimentaires. L'invention porte également sur des procédés de traitement utilisant l'antagoniste du récepteur de NK-1 et sur des compositions pharmaceutiques et les produits qu'elles contiennent.
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Use of nk-1 receptor antagonists for treating eating disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of nk-1 receptor antagonists for treating eating disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of nk-1 receptor antagonists for treating eating disorders will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2064524